Overview
EN ISO 8537:2016 - Sterile single-use syringes, with or without needle, for insulin (ISO 8537:2016) specifies requirements and test methods for empty, sterile, single‑use plastic insulin syringes that are filled by the end user and intended for immediate insulin injection. The standard covers human-use syringes for various insulin concentrations and excludes glass syringes, syringes for power‑driven pumps, pre‑filled syringes, and syringes intended to be stored after filling.
Key topics and technical requirements
EN ISO 8537:2016 addresses the full lifecycle of a sterile insulin syringe from materials to user information. Major technical topics include:
- Material selection - requirements for plastics and limits on extractables and leachable metals to reduce biological risk.
- Sterility and extraneous matter - criteria for acceptable particulate, acidity/alkalinity and cleanliness.
- Lubrication - guidance on syringe barrel and needle-tube lubrication to ensure smooth plunger action without compromising sterility or compatibility.
- Dimensions and fit - specifications for barrel, plunger stopper, finger grips, nozzle geometry and fit to ensure accurate dosing and compatibility.
- Plunger performance - fit, freedom from leakage past the plunger stopper and repeatable movement.
- Needle and hub - requirements for needle tubing, bond between hub and needle tube, and applicable needle types for the syringe variants.
- Performance tests - standard test environmental conditions and methods to assess dead space, leakage at the needle and past the plunger stopper.
- Packaging and labelling - unit and multiple‑unit packaging, sterile barriers, user packaging, storage containers and required manufacturer information.
- Risk and usability - links to risk management and usability processes (see ISO 14971 and ISO 62366‑1) to address safety and instructions for use.
Practical applications and who uses this standard
EN ISO 8537:2016 is used by:
- Medical device manufacturers designing or producing plastic insulin syringes for self‑injection.
- Quality assurance and regulatory teams to demonstrate conformity with essential requirements of EU medical device directives (see Annex ZA).
- Test laboratories conducting leakage, dead space and biocompatibility evaluations.
- Procurement and clinical staff who need specifications for device selection and safe usage guidance.
- Design engineers optimizing materials, lubrication and ergonomics for insulin delivery.
Related standards
Relevant references cited in EN ISO 8537:2016 include:
By following EN ISO 8537:2016, stakeholders ensure sterile, single‑use insulin syringes meet harmonized safety, performance and packaging expectations for end‑user filled insulin injection devices.
